This story has been updated from a previous version.

NEW YORK, May 17 - Lion Bioscience has licensed its SRS platform to Affymetrix for use in internal R&D as well as for a customer portal, Lion said Thursday.

The licensing deal will be for three years, Jan Mous, chief scientific officer of Lion, told GenomeWeb. No other terms of the agreement were disclosed, though Mous did call the size of the deal  "larger than usual" for Lion.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.